SleepRes announced today that it received FDA 510(k) clearance for its Kricket PAP device for treating obstructive sleep apnea (OSA).

Initiation of incretin receptor agonists vs SGLT2 inhibitors in adults with obesity, T2D, and obstructive sleep apnea is ...

SleepRes is ready to shake up the CPAP market after receiving U.S. Food and Drug Administration (FDA) clearance for its Kricket positive airway pressure (PAP) device, powered ...

Older adults who followed a structured health-related intervention experienced improved sleep-apnea related outcomes compared ...

Sulthiame reduced breathing interruptions in sleep apnea patients, pointing toward a viable drug treatment. A European clinical trial has found that the drug sulthiame can reduce breathing pauses and ...

A voluntary recall of millions of CPAP breathing machines, used mainly to treat sleep apnea, has many users wondering if they've been inhaling cancer-causing toxins in their sleep. At least 25 million ...

Obstructive sleep apnea affects the quality of life of millions of people, but current solutions are not always well accepted ...

Sleep apnea can be quite an unnoticed problem, but recent studies conduct research on how it might actually be more related ...

Please provide your email address to receive an email when new articles are posted on . Veterans with greater apnea-hypopnea index scores saw less improvement with esketamine for PTSD. This outcome ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said.